Akebia Therapeutics Inc (AKBA)
1.32
-0.07
(-5.04%)
USD |
NASDAQ |
Apr 19, 12:25
Akebia Therapeutics Revenue (TTM): 194.74M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 194.74M |
| September 30, 2023 | 194.33M |
| June 30, 2023 | 201.00M |
| March 31, 2023 | 270.99M |
| December 31, 2022 | 292.56M |
| September 30, 2022 | 294.46M |
| June 30, 2022 | 294.50M |
| March 31, 2022 | 221.04M |
| December 31, 2021 | 211.65M |
| September 30, 2021 | 210.01M |
| June 30, 2021 | 221.24M |
| March 31, 2021 | 258.47M |
| December 31, 2020 | 294.64M |
| Date | Value |
|---|---|
| September 30, 2020 | 308.16M |
| June 30, 2020 | 340.15M |
| March 31, 2020 | 350.81M |
| December 31, 2019 | 335.00M |
| September 30, 2019 | 325.30M |
| June 30, 2019 | 286.49M |
| March 31, 2019 | 234.48M |
| December 31, 2018 | 207.74M |
| September 30, 2018 | 238.45M |
| June 30, 2018 | 226.56M |
| March 31, 2018 | 206.29M |
| December 31, 2017 | 181.23M |
| September 30, 2017 | 92.20M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
194.33M
Minimum
Sep 2023
350.81M
Maximum
Mar 2020
268.71M
Average
286.49M
Median
Jun 2019